Development and validation of a mass spectrometric detection method of peginesatide in dried blood spots for sports drug testing

New Anemia Therapies: Translating Novel Strategies From Bench to Bedside

(2011) Iain C. Macdougall   AMERICAN JOURNAL OF KIDNEY DISEASES

Dried blood spots (DBS) for doping control analysis

(2011) Andreas Thomas et al.   Drug Testing and Analysis

Methods for detection and confirmation of Hematide™/peginesatide in anti-doping samples

(2011) Nicolas Leuenberger et al.   FORENSIC SCIENCE INTERNATIONAL

Quantitative analysis of NIM811, a cyclophilin inhibitor, in human dried blood spots using liquid chromatography–tandem mass spectrometry

(2011) Wenkui Li et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Synthesis, characterisation, and mass spectrometric detection of a pegylated EPO-mimetic peptide for sports drug testing purposes

(2011) Ines Möller et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY

Pre-cut dried blood spot (PCDBS): an alternative to dried blood spot (DBS) technique to overcome hematocrit impact

(2011) Nikolay Youhnovski et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY

Approaches for the rapid identification of drug metabolites in early clinical studies

(2011) Gordon J Dear et al.   Bioanalysis

Application of DBS for the quantitative assessment of a protein biologic using on-card digestion LC–MS/MS or immunoassay

(2011) Jonathan Kehler et al.   Bioanalysis

GlaxoSmithKline’s experience of incurred sample reanalysis for dried blood spot samples

(2011) Matthew Barfield et al.   Bioanalysis

Dried blood spots, pharmacokinetic studies and better medicines for children

(2011) Hitesh C Pandya et al.   Bioanalysis

Quantitation of therapeutic proteins following direct trypsin digestion of dried blood spot samples and detection by LC–MS-based bioanalytical methods in drug discovery

(2011) Bogdan G Sleczka et al.   Bioanalysis

Facilitating pharmacokinetic studies in children: a new use of dried blood spots

(2010) P. Patel et al.   ARCHIVES OF DISEASE IN CHILDHOOD

Validation of a bioanalytical method for the quantification of a therapeutic peptide, ramoplanin, in human dried blood spots using LC-MS/MS

(2010) Matthew F. Ewles et al.   BIOMEDICAL CHROMATOGRAPHY

Dexamethasone quantification in dried blood spot samples using LC–MS: The potential for application to neonatal pharmacokinetic studies

(2010) Parul Patel et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Long-term stability of thyroid hormones and DNA in blood spots kept under varying storage conditions

(2010) Asmahan A. EL Ezzi et al.   PEDIATRICS INTERNATIONAL

Application of DBS for quantitative assessment of the peptide Exendin-4; comparison of plasma and DBS method by UHPLC–MS/MS

(2010) Jonathan R Kehler et al.   Bioanalysis

Increasing efficiency for dried blood spot analysis: prospects for automation and simplified sample analysis

(2010) Philip Wong et al.   Bioanalysis

Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules

(2009) Wenkui Li et al.   BIOMEDICAL CHROMATOGRAPHY

Analysis of cyclosporin A in dried blood spots using liquid chromatography tandem mass spectrometry

(2009) A.J. Wilhelm et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

A Peptide-Based Erythropoietin-Receptor Agonist for Pure Red-Cell Aplasia

(2009) Iain C. Macdougall et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dried Blood Spot Methods in Therapeutic Drug Monitoring: Methods, Assays, and Pitfalls

(2009) Peter M Edelbroek et al.   THERAPEUTIC DRUG MONITORING

Tryptic Peptide Analysis of Ceruloplasmin in Dried Blood Spots Using Liquid Chromatography-Tandem Mass Spectrometry: Application to Newborn Screening

(2008) A. deWilde et al.   CLINICAL CHEMISTRY

Population Pharmacokinetics and Pharmacodynamics of Peptidic Erythropoiesis Receptor Agonist (ERA) in Healthy Volunteers

(2007) Sukyung Woo et al.   JOURNAL OF CLINICAL PHARMACOLOGY